| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.1 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |